IAS conference concludes with positive news on HIV prevention

"Scientists on Wednesday wrapped up their biggest forum in the 30-year history of AIDS, unveiling stunning weapons to prevent the spread of HIV," Agence France-Presse reports about the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Rome. The article summarizes study findings presented at the conference on treatment as prevention, pre-exposure prophylaxis (PrEP), male circumcision, and the "once-unimaginable goal" of finding a cure (Ingham, 7/20).

Three studies on male circumcision were presented on Wednesday, with one study showing that "[n]ew cases of HIV among men fell by an astonishing 76 percent after a circumcision program was launched in a South African township," another Agence France-Presse article reports (7/20). According to Bloomberg News, the findings "are the first evidence that circumcision is altering the course of the world's deadliest infectious disease in the nation hit hardest by it" (Bennett, 7/20).

Another study presented on Wednesday that was conducted "from 2004 to 2010 in seven African countries - Kenya, Uganda, Rwanda, Botswana, Zambia, Tanzania and South Africa" - found that women living with HIV infection who were taking hormonal contraception were about twice as likely to transmit the virus to their sexual partners compared with their counterparts who were not on hormonal birth control, the Associated Press reports. The study also showed that women on hormonal contraception were about twice as likely to contract HIV from an infected partner than women not taking hormones, the news agency notes (7/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response